ACT-132577
- CAS No.
- 1103522-45-7
- Chemical Name:
- ACT-132577
- Synonyms
- ACT-132577;Aprocitentan;Despropyl Macitentan;Macitentan ACT-132577;N-Despropyl Macitentan;Macitentan Impurity 07;Macitentan ACT-132577-D4;Macitentan N-Despropyl Impurity;Despropyl Macitentan (COLD SHIPMENT REQUIRED);APROCITENTAN; ACT-132577; ACT 132577; ACT132577; DESPROPYL MACITENTAN
- CBNumber:
- CB12685914
- Molecular Formula:
- C16H14Br2N6O4S
- Molecular Weight:
- 546.19
- MDL Number:
- MFCD28155267
- MOL File:
- 1103522-45-7.mol
- MSDS File:
- SDS
Melting point | 139-141°C |
---|---|
Boiling point | 705.0±70.0 °C(Predicted) |
Density | 1.841±0.06 g/cm3(Predicted) |
storage temp. | -20°C Freezer |
solubility | Chloroform (Slightly, Heated), Methanol (Slightly, Heated) |
form | Solid |
pka | 13.56±0.60(Predicted) |
color | White to Off-White |
FDA UNII | MZI81HV01P |
ACT-132577 price
Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|---|
TRC | D297305 | N-DespropylMacitentan | 1103522-45-7 | 10mg | $580 | 2021-12-16 | Buy |
TRC | D297305 | N-DespropylMacitentan | 1103522-45-7 | 5mg | $305 | 2021-12-16 | Buy |
TRC | D297305 | N-DespropylMacitentan | 1103522-45-7 | 50mg | $1635 | 2021-12-16 | Buy |
ChemScene | CS-2687 | Aprocitentan 98.13% | 1103522-45-7 | 100mg | $2520 | 2021-12-16 | Buy |
ChemScene | CS-2687 | Aprocitentan 98.13% | 1103522-45-7 | 5mg | $420 | 2021-12-16 | Buy |
ACT-132577 Chemical Properties,Uses,Production
Uses
N-Despropyl-macitentan, is an active metabolite which is part of a family of endothelin receptor antagonist that allows for treatment of pulmonary arterial hypertension (PAH)
Definition
ChEBI: ACT-132577 is a member of the class of sulfamides in which one of the amino groups of sulfonamide is substituted by a 5-(4-bromophenyl)-6-{2-[(5-bromopyrimidin-2-yl)oxy]ethoxy}pyrimidin-4-yl group. An active metabolite of macitentan (obtained by oxidative depropylation), an orphan drug used for the treatment of pulmonary arterial hypertension. It has a role as an antihypertensive agent, an endothelin receptor antagonist, a drug metabolite and a xenobiotic metabolite. It is an aromatic ether, an organobromine compound, a member of pyrimidines and a member of sulfamides. It is functionally related to an ethylene glycol.
ACT-132577 Preparation Products And Raw materials
Raw materials
Preparation Products
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
Jinan Jianfeng Chemical Co., Ltd | 0531-88110457; +8615562555968 | info@pharmachemm.com | China | 248 | 58 |
ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 | ivan@atkchemical.com | China | 32957 | 60 |
Jinan Carbotang Biotech Co.,Ltd. | +8615866703830 | figo.gao@foxmail.com | China | 8497 | 58 |
Shochem(Shanghai) Co.,Ltd | 86-21-50800795 | info@shochem.com | CHINA | 288 | 58 |
ENBRIDGE PHARMTECH CO., LTD. | +8613812269233 | tinayang@enbridgepharm.com | China | 322 | 58 |
TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 | marketing@targetmol.com | United States | 32165 | 58 |
Career Henan Chemica Co | +86-0371-86658258 +8613203830695 | laboratory@coreychem.com | China | 30240 | 58 |
HANGZHOU CLAP TECHNOLOGY CO.,LTD | 86-571-88216897,88216896 13588875226 | sales@hzclap.com | CHINA | 6312 | 58 |
sgtlifesciences pvt ltd | +8617013299288 | dj@sgtlifesciences.com | China | 12373 | 58 |
Hefei TNJ Chemical Industry Co.,Ltd. | +86-0551-65418684 +8618949823763 | sales@tnjchem.com | China | 25356 | 58 |
View Lastest Price from ACT-132577 manufacturers
Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
---|---|---|---|---|---|---|---|---|
2024-11-29 | Aprocitentan
1103522-45-7
|
US $0.00-0.00 / g | 1g | 99% | 1000 | Jinan Jianfeng Chemical Co., Ltd | ||
2024-11-19 | Aprocitentan
1103522-45-7
|
US $53.00-178.00 / mg | 99.17% | 10g | TargetMol Chemicals Inc. |
- Aprocitentan
1103522-45-7
- US $0.00-0.00 / g
- 99%
- Jinan Jianfeng Chemical Co., Ltd
- Aprocitentan
1103522-45-7
- US $53.00-178.00 / mg
- 99.17%
- TargetMol Chemicals Inc.